Daewoong pharmaceutical

069620.KO

101.62 USD

0.22

+0.22%

Overview

Last close

101.62 usd

Market cap

1.17B usd

52 week high

134.42 usd

52 week low

76.68 usd

Target price

148.63 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.1016

Price/Book Value

1.7201

Enterprise Value

1.69B usd

EV/Revenue

1.5196

EV/EBITDA

9.3473

Key financials

Revenue TTM

1.06B usd

Gross Profit TTM

553.19M usd

EBITDA TTM

165.84M usd

Earnings per Share

N/A usd

Dividend

0.4 usd

Total assets

1.64B usd

Net debt

456.36M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.